From: Application of MR-ProADM to predict prevention of hospitalisation, derived from a multi-centre study
 | Graziadio et al [2] | Saeed et al [1] | |
---|---|---|---|
MR-proADM | Sensitivity | 0.60 [0.44–0.71] | 0.75 [0.72–0.78] |
Specificity | 0.60 [0.53–0.66] | 0.80 [0.74–0.84] | |
LR+ | 1.24 [0.82–1.86] | 3.69 [2.90–4.71] | |
LR− | 0.78 [0.44–1.37] | 0.31 [0.27–0.35] | |
PPV | 0.19 [0.14–0.87] | 0.93 [0.91–0.95] | |
NPV | 0.87 [0.79–0.92] | 0.48 [0.43–0.52] | |
CRP | Sensitivity | 0.85 [0.62–0.97] | 0.42 [0.39–0.45] |
Specificity | 0.21 [0.13–0.30] | 0.77 [0.72–0.82] | |
LR+ | 1.07 [0.87–1.32] | 1.84 [1.45–2.33] | |
LR− | 0.72 [0.24–2.19] | 0.75 [0.69–0.82] | |
PPV | 0.18 [0.15–0.21] | 0.87 [0.83–0.89] | |
NPV | 0.88 [0.70–0.96] | 0.27 [0.24–0.31] |